Federica Pulvirenti Selected Research

Federica Pulvirenti Research Topics

7	Primary Immunodeficiency Diseases 01/2022 - 10/2014
6	COVID-19 04/2022 - 01/2020
5	Infections 11/2021 - 09/2011
4	Common Variable Immunodeficiency 02/2019 - 01/2014
3	Reinfection 01/2022 - 07/2016
2	Hypersensitivity (Allergy) 01/2022 - 11/2018
2	Lymphoma (Lymphomas) 01/2021 - 09/2011
2	Lung Diseases (Lung Disease) 01/2020 - 01/2019
2	Hemolysis 07/2016 - 05/2015
1	Bruton type agammaglobulinemia 11/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019
1	Persistent Infection 01/2019
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2019
1	Inflammation (Inflammations) 07/2016
1	Splenomegaly 07/2016
1	Bronchiectasis 10/2014
1	Pneumonia (Pneumonitis) 10/2014
1	Cryoglobulinemia 09/2011

7	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 01/2014
4	Immunoglobulin G (IgG)IBA 11/2021 - 10/2014
3	Monoclonal AntibodiesIBA 04/2022 - 09/2011
2	Secretory Immunoglobulin A (SIgA)IBA 01/2022 - 01/2019
2	AntibodiesIBA 01/2022 - 01/2019
2	BNT162 VaccineIBA 11/2021 - 10/2021
2	VaccinesIBA 11/2021 - 10/2021
1	AntigensIBA 01/2021
1	MacrolidesIBA 01/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2019
1	Immunoglobulin E (IgE)IBA 11/2018
1	IsoantibodiesIBA 07/2016
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2016
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 09/2015
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2015
1	Immunoglobulin A (IgA)IBA 10/2014
1	Antiviral Agents (Antivirals)IBA 09/2011
1	Rituximab (Mabthera)FDA Link 09/2011

5	Therapeutics 01/2022 - 09/2011